Can cannabis calm Alzheimer's agitation? new trial seeks answers

NCT ID NCT05543681

Recruiting now Symptom relief Sponsor: IGC Pharma, LLC Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 18 times

Summary

This study tests an oral medication called IGC-AD1, made from a cannabis compound (THC), to see if it can safely reduce agitation in people with mild to severe Alzheimer's disease. About 164 participants will take the drug or a placebo twice daily for several weeks. The goal is to improve quality of life for patients and ease the burden on their caregivers.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

BayCare Health System Inc.
RECRUITING

St. Petersburg, Florida, 33705, United States
Baycrest Academy for Research and Education , University of Toronto
RECRUITING

Toronto, Ontario, ON M6A 2E1, Canada
Baylor Scott and White Research Institute
RECRUITING

Dallas, Texas, 75231, United States
Butler Hospital, Brown University
RECRUITING

Providence, Rhode Island, 02906, United States
Central Miami Medical Institute
RECRUITING

Miami, Florida, 33125, United States
ClinCloud, LLC
ACTIVE_NOT_RECRUITING

Maitland, Florida, 32751, United States
ClinCloud, LLC
RECRUITING

Melbourne, Florida, 32940, United States
Dent Neurologic Institute
RECRUITING

Amherst, New York, 02459, United States
Dominion Medical Associates, Inc.
RECRUITING

Richmond, Virginia, 23219, United States
Douglas Hospital Research Center, McGill university
RECRUITING

Montreal, Quebec, H4H 1R3, Canada
Grupo de Neurociencias de Antioquia, Universidad de Antioquia
ACTIVE_NOT_RECRUITING

Medellín, Antioquia, Colombia
Hamilton Health Sciences , Mcmaster University
RECRUITING

Hamilton, Ontario, L8M 1W9, Canada
Ichor Research
RECRUITING

Syracuse, New York, 13210, United States
Instituto Sanacoop
COMPLETED

Bayamón, Bayamón, 00961, Puerto Rico
Integrative Clinical Trials, LLC
NOT_YET_RECRUITING

Brooklyn, New York, 11229, United States
Island Health Authorities
RECRUITING

Victoria, British Columbia, V8R 1J8, Canada
Kerwin Medical Center
RECRUITING

Dallas, Texas, 75231, United States
Lynn Health Science Institute (LHSI)
RECRUITING

Oklahoma City, Oklahoma, 73112, United States
MedStar Franklin Square Medical Center Neurology
RECRUITING

Baltimore, Maryland, 21237, United States
Medstar Montgomery Medical Center
RECRUITING

Olney, Maryland, 20832, United States
Medstar Southern Maryland Hospital Center
RECRUITING

Clinton, Maryland, 20735, United States
Miami Jewish Health
RECRUITING

Miami, Florida, 33137, United States
Neurostudies Inc.
RECRUITING

Port Charlotte, Florida, 33952, United States
SCB Research Center Corp
RECRUITING

Bayamón, Puerto Rico, 00961, Puerto Rico
Senior Adults Specialty Research
RECRUITING

Austin, Texas, 78757, United States
Tandem Clinical Research GI, LLC
RECRUITING

Metaire, Louisiana, 70006, United States
Tekton Research LLC
RECRUITING

St Louis, Missouri, 63128, United States
The Alliance, Medical Sciences Campus University of Puerto Rico
RECRUITING

Rio Piedras, Puerto Rico, 00935, Puerto Rico
University of South Florida Department of Psychiatry and Behavioral Neurosciences
RECRUITING

Tampa, Florida, 33613, United States
Visionary Investigators Network
RECRUITING

Miami, Florida, 33133, United States

Conditions

Explore the condition pages connected to this study.

AGGRESSION AGITATION,PSYCHOMOTOR ALZHEIMER DISEASE CARE GIVING BURDEN CARE GIVING BURDEN NPS